Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,967 | -3,867 | -2,825 | -1,663 | -537 |
| Depreciation Amortization | 92 | 252 | 162 | 109 | 53 |
| Accounts receivable | 348 | -278 | -191 | -19 | -354 |
| Other Working Capital | -329 | 883 | 882 | 1,120 | 553 |
| Other Operating Activity | 59 | 1,593 | 890 | 281 | 230 |
| Operating Cash Flow | $-1,797 | $-1,417 | $-1,082 | $-172 | $-55 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34 | -36 | -36 | -23 | -23 |
| Other Investing Activity | 0 | -49 | -49 | 0 | 0 |
| Investing Cash Flow | $-34 | $-85 | $-85 | $-23 | $-23 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -70 | -264 | -199 | -131 | -65 |
| Common Stock Issued | 163 | 501 | 473 | 359 | 62 |
| Other Financing Activity | 188 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $281 | $237 | $274 | $228 | $-3 |
| Exchange Rate Effect | -2 | -11 | -6 | -4 | -5 |
| Beginning Cash Position | 6,973 | 8,249 | 8,249 | 8,249 | 8,249 |
| End Cash Position | 5,421 | 6,973 | 7,350 | 8,278 | 8,163 |
| Net Cash Flow | $-1,552 | $-1,276 | $-899 | $29 | $-86 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,797 | -1,417 | -1,082 | -172 | -55 |
| Capital Expenditure | -34 | -36 | -36 | -23 | -23 |
| Free Cash Flow | -1,831 | -1,453 | -1,118 | -195 | -78 |